Latent Labs builds generative foundation models that treat biology as a programmable substrate. Their 'Latent-X' models go beyond structure prediction to generate novel biological designs with specific functional properties. The company focuses on the generative design of antibodies, enzymes, and other protein structures, effectively allowing scientists to 'code' biological functions for therapeutic and industrial applications. The approach compresses traditional R&D timelines, offering systemic cost reductions in therapeutic development and biological engineering.